An open label, randomized, placebo-controlled, clinical study to evaluate the safety and efficacy of Evocus Black Alkaline Drink in body Hydration, Acidity regulation and Detoxification among healthy, adult subjects.

A V Organics0 个研究点目标入组 34 人开始时间: 待定最近更新: 2023年5月1日

试验速览

暂无简介。

•1) Age: 18 to 60 years (both inclusive) at the time of consent.
•2) Sex: Healthy Male and non-pregnant/non-lactating female.
•3) BMI between 18.5 to 29.9.
•4) Subjects having either of the classical sign and symptoms of gastroesophageal reflux disease (GERD) i.e., Stomachache, Heartburn, Heavy Stomach, Lower Abdominal Pain and Bloated Stomach at the time of screening.

•1) Underweight or obese subjects (BMI <18.5 and >=30).
•2) Currently taking any medication for diuretic, blood thinning or blood pressure medicines).
•3) Any Chronic illness or health condition such as cancer, diabetes, Peripheral Artery Disease, CKD, previous major surgery, HIV, hepatitis etc. that can interfere with the outcome of the study.
•4) Subjects working in harsh condition or are exposed to sun for most of the day (e.g., labourers), or in night shifts.
•5) Any pathological problem associated with gastroesophageal reflux disease including Barretts esophagus and malignancy

发起方

A V Organics